semaglutide litigation Lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass over the drugs Ozempic® Lawsuit | July 2026
Description
However, studies indicate 50 to 72 percent of patients discontinue the drugs within a year, often because of the side effects
In the eighth trial of the STEP program (for the Semaglutide Treatment Effect in People with obesity), researchers compared semaglutide directly to liraglutide in comparable doses.19 After 68 weeks, participants on liraglutide lost an average of 6.4% body weight, but those on semaglutide saw nearly triple that effect, losing an average of 15.8% of body weight

In 824 Japanese older adults, individuals with T2DM had 2.5-fold higher odds of developing sarcopenia over 5 years compared to counterparts without T2DM [24]

Many clients achieve their best results when combining medical treatments with lifestyle modifications
Here is how to get the most from abdominal injections
